RBC Capital Upgrades Cardiome Pharma (CRME) to Outperform
Tweet
Share
E-mailGet Alerts CRME Hot Sheet
Price: $2.33 --0%
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE
RBC Capital upgraded Cardiome Pharma (NASDAQ: CRME) from Sector Perform to Outperform. PT increased to $8.40.
For more ratings news on Cardiome Pharma click here and for the rating history of Cardiome Pharma click here.
Shares of Cardiome Pharma closed at $4.41 yesterday.
For more ratings news on Cardiome Pharma click here and for the rating history of Cardiome Pharma click here.
Shares of Cardiome Pharma closed at $4.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Grupo Aeroportuario del Pacifico SAB de CV (GAPB:MM) (PAC) to Buy
- ICICI Securities Upgrades Tech Mahindra Ltd. (TECHM:IN) to Hold (3)
- BofA Securities Upgrades Fervo Energy (FRVO) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
